T +1 650 213 0300
Ning Zhang is an associate in the Mergers & Acquisitions Practice Group.
Ning advises clients on cross-border mergers and acquisitions, joint ventures, private equity investments and direct investment projects.
Shenzhen Hepalink Pharmaceutical Co., Ltd. and its US subsidiary, Hepalink USA Inc., in its US$337.5 million acquisition of 100 percent of the equity interest of Scientific Protein Laboratories, LLC, one of the leading global, independent manufacturers and suppliers of active pharmaceutical ingredients.
Industrial and Commercial Bank of China Limited (ICBC), the world's largest bank by market capitalization, on its proposed subscription of newly issued shares in SinoPac Financial Holdings (a Taiwan-listed financial holding company) for US$784 million or its wholly owned subsidiary Bank SinoPac for US$624 million, by way of private placement.